{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T19:50:51Z","timestamp":1787946651832,"version":"build-2784847793"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002657","name":"Istanbul \u00dcniversitesi","doi-asserted-by":"publisher","award":["51374"],"award-info":[{"award-number":["51374"]}],"id":[{"id":"10.13039\/501100002657","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002657","name":"Istanbul \u00dcniversitesi","doi-asserted-by":"publisher","award":["52812"],"award-info":[{"award-number":["52812"]}],"id":[{"id":"10.13039\/501100002657","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.imlet.2021.09.008","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T02:53:05Z","timestamp":1632970385000},"page":"46-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Functions of NK and iNKT cells in pediatric and adult CVID, ataxia telangiectasia and agammaglobulinemia patients"],"prefix":"10.1016","volume":"240","author":[{"given":"Suzan","family":"Adin-Cinar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metin Yusuf","family":"Gelmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilgun","family":"Akdeniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulce","family":"Ozcit-Gurel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5821-3963","authenticated-orcid":false,"given":"Ayca","family":"Kiykim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Karakoc-Aydiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isil","family":"Barlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0721-6213","authenticated-orcid":false,"given":"Gunnur","family":"Deniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.imlet.2021.09.008_bib0001","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","article-title":"Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification","volume":"40","author":"Bousfiha","year":"2020","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.imlet.2021.09.008_bib0002","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.2011.06242.x","article-title":"Thirty years of primary immunodeficiencies in Turkey","volume":"1238","author":"Sanal","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2 Suppl 2","key":"10.1016\/j.imlet.2021.09.008_bib0003","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1016\/j.jaci.2009.07.053","article-title":"Primary immunodeficiencies","volume":"125","author":"Notarangelo","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2B","key":"10.1016\/j.imlet.2021.09.008_bib0004","first-page":"1263","article-title":"Development of cancer in patients with primary immunodeficiencies","volume":"28","author":"Salavoura","year":"2008","journal-title":"Anticancer Res."},{"key":"10.1016\/j.imlet.2021.09.008_bib0005","first-page":"162","article-title":"Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency","volume":"5","author":"Al-Herz","year":"2014","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.imlet.2021.09.008_bib0006","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11882-017-0746-6","article-title":"Dysregulation of innate lymphoid cells in common variable immunodeficiency","volume":"17","author":"Maglione","year":"2017","journal-title":"Curr. Allergy Asthma Rep."},{"issue":"2","key":"10.1016\/j.imlet.2021.09.008_bib0007","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2141.2010.08077.x","article-title":"Update on the hyper immunoglobulin M syndromes","volume":"149","author":"Davies","year":"2010","journal-title":"Br. J. Haematol."},{"issue":"10","key":"10.1016\/j.imlet.2021.09.008_bib0008","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/carcin\/bgx074","article-title":"Telomere length, ATM mutation status and cancer risk in ataxia-telangiectasia families","volume":"38","author":"Renault","year":"2017","journal-title":"Carcinogenesis"},{"issue":"17","key":"10.1016\/j.imlet.2021.09.008_bib0009","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1200\/JCO.2013.53.1046","article-title":"Bruton's tyrosine kinase: from X-linked agammaglobulinemia toward targeted therapy for B-cell malignancies","volume":"32","author":"Ponader","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.imlet.2021.09.008_bib0010","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1586\/eci.09.27","article-title":"Natural killer cells: versatile roles in autoimmune and infectious diseases","volume":"5","author":"Aktas","year":"2009","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2021.09.008_bib0011","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cellimm.2008.08.007","article-title":"Relationship between CD107a expression and cytotoxic activity","volume":"254","author":"Aktas","year":"2009","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.imlet.2021.09.008_bib0012","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.3389\/fimmu.2019.01999","article-title":"NK cell dysfunction and checkpoint immunotherapy","volume":"10","author":"Bi","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2021.09.008_bib0013","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000323963","article-title":"Modifications of the innate immune system in atopic dermatitis","volume":"3","author":"Maintz","year":"2011","journal-title":"J. Innate Immun."},{"issue":"8","key":"10.1016\/j.imlet.2021.09.008_bib0014","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1182\/blood-2002-09-2876","article-title":"CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity","volume":"101","author":"Fehniger","year":"2003","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.imlet.2021.09.008_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8091492","article-title":"NK cell plasticity in cancer","volume":"8","author":"Liu","year":"2019","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.imlet.2021.09.008_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0329-9","article-title":"Invariant NKT cells facilitate cytotoxic T-cell activation via direct recognition of CD1d on T cells","volume":"51","author":"Qin","year":"2019","journal-title":"Exp. Mol. Med."},{"issue":"11","key":"10.1016\/j.imlet.2021.09.008_bib0017","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.it.2019.09.008","article-title":"Immune networks and therapeutic targeting of iNKT cells in cancer","volume":"40","author":"Fujii","year":"2019","journal-title":"Trends Immunol."},{"issue":"8","key":"10.1016\/j.imlet.2021.09.008_bib0018","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10875-015-0198-5","article-title":"The 2015 IUIS phenotypic classification for primary immunodeficiencies","volume":"35","author":"Bousfiha","year":"2015","journal-title":"J. Clin. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2021.09.008_bib0019","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.imlet.2021.09.008_bib0020","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.3389\/fimmu.2019.02915","article-title":"NK cell metabolism and TGFbeta - implications for immunotherapy","volume":"10","author":"Slattery","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2021.09.008_bib0021","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.3389\/fimmu.2019.01812","article-title":"On the way to become a natural killer cell","volume":"10","author":"Di Vito","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2021.09.008_bib0022","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/pai.13020","article-title":"Ataxia-telangiectasia: a review of clinical features and molecular pathology","volume":"30","author":"Amirifar","year":"2019","journal-title":"Pediatr. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2021.09.008_bib0023","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4049\/jimmunol.1101909","article-title":"Classical ataxia telangiectasia patients have a congenitally aged immune system with high expression of CD95","volume":"189","author":"Carney","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2021.09.008_bib0024","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/B978-0-12-800267-4.00003-1","article-title":"Recognition of tumors by the innate immune system and natural killer cells","volume":"122","author":"Marcus","year":"2014","journal-title":"Adv. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2021.09.008_bib0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s40425-018-0392-0","article-title":"A possible new pathway in natural killer cell activation also reveals the difficulty in determining human NK cell function in cancer","volume":"6","author":"Canter","year":"2018","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.imlet.2021.09.008_bib0026","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.cell.2017.11.037","article-title":"Natural killer cells control tumor growth by sensing a growth factor","volume":"172","author":"Barrow","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2021.09.008_bib0027","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3389\/fimmu.2016.00365","article-title":"Cancers related to immunodeficiencies: update and perspectives","volume":"7","author":"Mortaz","year":"2016","journal-title":"Front. Immunol"},{"key":"10.1016\/j.imlet.2021.09.008_bib0028","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3389\/fimmu.2019.00909","article-title":"The natural cytotoxicity receptors in health and disease","volume":"10","author":"Barrow","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2021.09.008_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2017.08.109","article-title":"Role of interleukin (IL)-17 and T-helper (Th)17 cells in cancer","volume":"493","author":"Song","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.imlet.2021.09.008_bib0030","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3109\/08830185.2014.952414","article-title":"The role of T helper 17 cells and other IL-17-producing cells in bone resorption and remodeling","volume":"34","author":"Liu","year":"2015","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.imlet.2021.09.008_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2021.04.008","article-title":"Inflammatory status might direct ILC and NK cells to IL-17 expressing ILC3 and NK subsets in Behcet's disease","volume":"235","author":"Gelmez","year":"2021","journal-title":"Immunol. Lett."},{"issue":"12","key":"10.1016\/j.imlet.2021.09.008_bib0032","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.4049\/jimmunol.1402529","article-title":"Poly(inosinic-cytidylic) acid-triggered exacerbation of experimental asthma depends on IL-17A produced by NK cells","volume":"194","author":"Lunding","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2021.09.008_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2020.103209","article-title":"Natural killer cells in recurrent miscarriage: an overview","volume":"142","author":"Guerrero","year":"2020","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.imlet.2021.09.008_bib0034","series-title":"X-linked Agammaglobulinemia","author":"Lackey","year":"2020"},{"issue":"8","key":"10.1016\/j.imlet.2021.09.008_bib0035","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.autrev.2016.03.018","article-title":"IVIG in autoimmune disease - potential next generation biologics","volume":"15","author":"Zuercher","year":"2016","journal-title":"Autoimmun. Rev."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247821001498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247821001498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:40:11Z","timestamp":1759045211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247821001498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":35,"alternative-id":["S0165247821001498"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2021.09.008","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functions of NK and iNKT cells in pediatric and adult CVID, ataxia telangiectasia and agammaglobulinemia patients","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2021.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}